Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications.
Genes (Basel)
; 14(9)2023 08 23.
Article
in En
| MEDLINE
| ID: mdl-37761809
ABSTRACT
The goal of regenerative medicine is to achieve tissue regeneration. In the past, commonly used techniques included autologous or allogeneic transplantation and stem cell therapy, which have limitations, such as a lack of donor sites in the case of autologous transplantation and the invasiveness of stem cell harvesting. In recent years, research has, therefore, focused on new and less invasive strategies to achieve tissue regeneration. A step forward in this direction has been made with the development of autologous platelet concentrates (APCs), which are derived from the patient's own blood. They can be classified into three generations platelet-rich plasma (PRP), platelet-rich fibrin (PRF), and concentrated growth factors (CGFs). These APCs have different structural characteristics, depending on the distinctive preparation method, and contain platelets, leukocytes, and multiple growth factors, including those most involved in regenerative processes. The purpose of this review is to clarify the most used techniques in the field of regenerative medicine in recent years, comparing the different types of APCs and analyzing the preparation protocols, the composition of the growth factors, the level of characterization achieved, and their clinical applications to date.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Regenerative Medicine
/
Platelet-Rich Plasma
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Genes (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Italy
Publication country:
CH
/
SUIZA
/
SUÍÇA
/
SWITZERLAND